Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

In a recent study published in the US Centers for Disease Control and Prevention (CDC) emerging infectious diseases In the journal, researchers investigate the cross-reactivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with pre-pandemic malaria-exposed sera samples collected from Cambodia. Stady: SARS-CoV-2 cross-reactivity in pre-pandemic serum of malaria-infected subjects in rural areas, Cambodia. Image … Read more

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene

Using a synthetic short chain of chemically modified nucleotides engineered at the Institute of RNA Therapeutics at UMass Chan School of Medicine, Robert H. The ALS gene known as C9ORF72 in a pilot study of a single patient. C9ORF72 is the most common cause of familial amyotrophic lateral sclerosis (ALS) and familial frontotemporal dementia (FTD). … Read more

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

The Wistar Institute announces the start of a phase II clinical study of VK-2019 in patients with advanced Epstein-Barr Carcinoma (EBV)-nasopharyngeal carcinoma (NPC) and lymphoma. The study, which is being led by researchers at Stanford University School of Medicine, will include patients who have recurred, progressed after standard treatment, or who have not responded to … Read more